ArticleFrontiers in oncology2021

A Linear Discriminant Analysis Model Based on the Changes of 7 Proteins in Plasma Predicts Response to Anlotinib Therapy in Advanced Non-Small Cell Lung Cancer Patients.

Fei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.